TAUNS Laboratories, Inc.JP:197A
Market cap
¥52B
P/E ratio
6x
| 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Depreciation & amortization | 567 | 640 | 676 | 715 |
| Cash from operations | 10,695 | -3,158 | 9,935 | 6,818 |
| Capital expenditures | -2,265 | -1,089 | -3,752 | -4,680 |
| Cash from investing | -2,680 | -1,615 | -4,110 | -9,258 |
| Payments for dividends | -1,800 | -1,900 | -600 | -2,782 |
| Proceeds from issuance of term debt, net | 3,700 | - | 2,699 | 5,642 |
| Repayments of term debt | -5,560 | -732 | -732 | -757 |
| Cash from financing | -3,660 | -330 | 2,356 | 2,281 |